290 results
Page 6 of 15
8-K
EX-99.2
wxv4qkh 1j
14 Jan 15
Regulation FD Disclosure
12:00am
8-K
EX-10.1
95cyoi 03debjc
7 Jan 15
Entry into a Material Definitive Agreement
12:00am
424B3
e8d 55f7h
17 Dec 14
Prospectus supplement
12:00am
8-K
EX-99.1
jl50lw4 eqydrspvp9
11 Dec 14
Regulation FD Disclosure
12:00am
8-K
EX-4.1
r8sa9un1mb4
22 Oct 14
Transgenomic Announces $2.375 Million Private Placement Financing
12:00am
8-K
EX-99.1
kgcwpkjh 49z
22 Oct 14
Transgenomic Announces $2.375 Million Private Placement Financing
12:00am
8-K
EX-99.1
r4ir3eavp1qwv9cr
2 Jul 14
Selective Monetization of Research Market Assets Reflects Strategic Focus on Higher Growth olecular Diagnostics and Personalized Medicine Sectors
12:00am
8-K
EX-99.1
y7pnsad3a74jw72j
19 Mar 14
Dr. Michael A. Luther Joins Transgenomic’s Board of Directors
12:00am
8-K
EX-99.1
xuwmigtejd
12 Mar 14
Transgenomic Reports Fourth Quarter and Fiscal Year 2013 Financial Results
12:00am
8-K
EX-10.2
do17 xv2k68fz
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
8-K
EX-99.1
8aospbi9p
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
8-K
EX-99.1
fsfziuyh o08wpfn
6 Nov 13
Transgenomic Reports Third Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
a7po jpwxw
30 Sep 13
Transgenomic Announces Executive Changes
12:00am
8-K
EX-99.1
2zn2ok4vuzpaga8vdpzp
8 May 13
Transgenomic Reports First Quarter 2013 Financial Results
12:00am
424B3
tauoht56ht22
29 Mar 13
Prospectus supplement
12:00am